A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy

BACKGROUND: Small cell lung cancer (SCLC) makes up 13% of lung malignancies. Only one-third of SCLC patients received their diagnosis at the limited stage. Treatment for symptomatic extensive-stage (ES) SCLC with persistent intrathoracic disease is still controversial. The present research aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xun, Zheng, Zhiqin, Liu, Fangfang, Gao, Yuan, Zhang, Wenhui, Berardi, Rossana, Mohindra, Pranshu, Zhu, Zhengfei, Lin, Jie, Chu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182711/
https://www.ncbi.nlm.nih.gov/pubmed/34164267
http://dx.doi.org/10.21037/tlcr-21-211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182711/
https://www.ncbi.nlm.nih.gov/pubmed/34164267
http://dx.doi.org/10.21037/tlcr-21-211

Ejemplares similares